Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.13 -0.15 (-3.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Long-Term Investments (2022)

Updated

Corbus Pharmaceuticals Holdings (CRBP) reported Long-Term Investments of $16.75 million for Q4 2022.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Long-Term Investments (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 266.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 297.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.56 Bn
10 Corbus Pharmaceuticals Holdings 51.77 Mn -464.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 16.75 Mn
API Access

Corbus Pharmaceuticals Holdings Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CRBP&period=max&api_key=YOUR_API_KEY